← Every firm
Slate Run Pharmaceuticals FDA Recalls
3 recalls on file across drugs, 0 of them Class I and 1 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous UClass IIIFeb 12, 2026Labeling: Not Elsewhere Classified. The carton for Eptifibat |
| Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 4321Class IIMar 7, 2025CGMP deviations: The presence of nitrosamine impurity above |
| Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 4321Class IIMar 7, 2025CGMP deviations: The presence of nitrosamine impurity above |